You are here

Article info

Article menu

Download PDFPDF

Commentary
Key role of CD4+ T cells in determining CD8 function during CAR-T cell manufacture

Authors

  • J Joseph Melenhorst Cell Therapy & ImmunoEngineering Program, Cleveland Clinic Lerner Research Institute, Cleveland, Ohio, USAUniversity of Pennsylvania, Philadelphia, Pennsylvania, USADepartment of Pathology and Laboratory Medicine, Parker Institute for Cancer Immunotherapy at University of Pennsylvania, Philadelphia PubMed articlesGoogle scholar articles
  • Beatriz C Oliveira Cell Therapy & ImmunoEngineering Program, Cleveland Clinic Lerner Research Institute, Cleveland, Ohio, USA PubMed articlesGoogle scholar articles

Citation

Melenhorst JJ, Oliveira BC
Key role of CD4+ T cells in determining CD8 function during CAR-T cell manufacture
Journal for ImmunoTherapy of Cancer 2024;12:e008723. doi: 10.1136/jitc-2023-008723
Online issue publication 
March 13, 2024

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See http://creativecommons.org/licenses/by-nc/4.0/.